Search Results - "Guiu, Josep M"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    A scoping review of the role of managed entry agreements in upcoming drugs for amyotrophic lateral sclerosis: learning from the case of spinal muscular atrophy by García-Parra, Beliu, Guiu, Josep M, Povedano, MÓnica, Modamio, Pilar

    “…: The therapeutic options for spinal muscular atrophy (SMA) are encouraging. However, there is currently no cure for amyotrophic lateral sclerosis (ALS). The…”
    Get full text
    Journal Article
  2. 2

    Geographical distribution of clinical trials in amyotrophic lateral sclerosis: a scoping review by García-Parra, Beliu, Guiu, Josep M, Povedano, Mónica, Mariño, Eduardo L, Modamio, Pilar

    “…: Clinical trials location is determined by many factors, including the availability of patient populations, regulatory environment, scientific expertise, and…”
    Get full text
    Journal Article
  3. 3

    The Effect of the Drug-Related Problems Prevention Bundle on Early Readmissions in Patients From the Emergency Department: A Randomized Clinical Trial by Juanes, Ana, Ruíz, Jesús, Puig, Mireia, Blázquez, Marta, Gilabert, Antoni, López, Laia, Baena, M. Isabel, Guiu, Josep M., Antònia Mangues, Maria

    Published in The Annals of pharmacotherapy (01-09-2023)
    “…Background: Drug-related problems (DRPs) are prevalent and avoidable disease that patients experience due to drug use or nonuse. However, secondary prevention…”
    Get full text
    Journal Article
  4. 4

    Accuracy-based learning classifier systems: models, analysis and applications to classification tasks by Bernadó-Mansilla, Ester, Garrell-Guiu, Josep M

    Published in Evolutionary computation (01-09-2003)
    “…Recently, Learning Classifier Systems (LCS) and particularly XCS have arisen as promising methods for classification tasks and data mining. This paper…”
    Get more information
    Journal Article
  5. 5

    Advancing Hospital Pharmacy Practice Through New Competences in Advanced Therapy Medicinal Products by Segura, Josep M. Guiu

    “…[...]the implementation of ATMPs represents new strategic opportunities for hospital pharmacy development, such as ATMP noncommercial bioproduction, quality…”
    Get full text
    Journal Article
  6. 6
  7. 7

    How COVID-19 has impacted the role of pharmacists around the world by Jordan, Dominique, Guiu-Segura, Josep M, Sousa-Pinto, Gonçalo, Wang, Lin-Nam

    “…All over the world pharmacists are standing up to the challenge of COVID- 19 and showing their commitment to the communities they serve. As the COVID-19…”
    Get more information
    Journal Article
  8. 8

    Evaluating board certification within international advance pharmacy practice frameworks by Lawson, Brian E., Guiu-Segura, Josep M.

    Published in Farmacia hospitalaria (01-05-2022)
    “…Utilizing board certification to advance practice and promote specialization through formal assessment of pharmacists’ knowledge and skills is one way the…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Access to orphan drugs for the treatment of spinal muscular atrophy in Spain by García-Parra, B, Guiu, J M, Modamio, P, Martínez-Yélamos, A, Mariño-Hernández, E L, Povedano, M

    Published in Revista de neurologiá (01-11-2022)
    “…Spinal muscular atrophy (SMA) is a rare disease whose diagnosis and treatment are complex. In Spain, there are two orphan medicines that are currently financed…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Synthesis of trans-perhydroisoquinolines by 6- endo- trig radical cyclization of amino-tethered vinyl bromides and cyclohexenes by Quirante, Josefina, Vila, Xavier, Paloma, Laura, Guiu, Josep M., Bonjoch, Josep

    Published in Tetrahedron (05-02-2007)
    “…Bu 3SnH-promoted cyclization of several N-(2-bromoprop-2-enyl)- N-[(4-oxocyclohex-1-enyl)methyl]alkylamines is reported. It has been found that the generated…”
    Get full text
    Journal Article